Alethea Bernice Tabor

Title: Alethea Bernice Tabor: Innovator in Biologically-Active Material Delivery

Introduction

Alethea Bernice Tabor is a prominent inventor based in London, GB. She has made significant contributions to the field of non-viral gene delivery systems. With a total of 3 patents, her work focuses on innovative methods for delivering biologically-active materials to cells.

Latest Patents

One of her latest patents is titled "Lipids and complexes for the delivery of biologically-active material to cells." This invention involves a lipid comprising a tri-chain cation that has a cationic head group and three or more hydrocarbyl groups. It is designed for use in non-viral gene delivery systems, particularly in the formation of lipopolyplex transfection vectors. Exceptionally good nucleic acid transfection is observed when nucleic acid and targeting peptides are formulated with the lipid of the invention into a LPD complex. Another notable patent is "Materials and complexes for the delivery of biologically-active materials to cells." This invention provides a peptide derivative of a specific formula and a lipid derivative that finds use in non-viral gene delivery systems.

Career Highlights

Alethea has worked with notable companies such as UCL Biomedica Plc and UCL Business Plc. Her experience in these organizations has contributed to her expertise in the field of biomedical innovations.

Collaborations

Throughout her career, Alethea has collaborated with esteemed colleagues, including Helen Claire Hailes and Stephen Lewis Hart. These partnerships have further enhanced her research and development efforts.

Conclusion

Alethea Bernice Tabor is a trailblazer in the field of biologically-active material delivery, with a focus on non-viral gene delivery systems. Her innovative patents and collaborations highlight her significant contributions to the scientific community.